Opinion|Videos|November 7, 2024
Types of Genetic Testing for Epilepsy Diagnosis
Author(s)John Michael Schreiber, MD, FAES
Key Takeaways
- Whole genome sequencing (WGS) analyzes the entire genome, providing comprehensive insights into genetic variations and potential health implications.
- Whole exome sequencing (WES) focuses on coding regions, identifying mutations in protein-coding genes that may cause disease.
John Michael Schreiber, MD, provides an overview of genetic testing, detailing the different types, including whole genome sequencing (WGS), whole exome sequencing (WES), multigene panels, comparative genomic hybridization (CGH), and chromosome microarray (CMA).
Advertisement
Episodes in this series
- Please provide an overview of genetic testing.
- What are the different types of genetic testing?
- Whole genome sequencing (WGS)
- Whole exome sequencing (WES)
- Multigene panel
- Comparative genomic hybridization (CGH)
- Chromosome microarray (CMA)
Advertisement
Related to this article
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 6, 2026.
Williams, MD, is joined by Marcus Gates, MD, and they discuss recognizing cervical nerve root and spinal cord compression, navigating treatment options, and determining when surgery may be appropriate.
Servier reported that sevasemten did not meet its primary or secondary endpoints in the pivotal GRAND CANYON trial for Becker muscular dystrophy.
QurAlis reported interim ANQUR trial results showing target engagement, a biomarker signal, and a trend toward slower functional decline with QRL-201 in ALS.
An epileptologist at Cleveland Clinic discussed findings from a recently published study of lifestyle interventions in epilepsy and why these approaches should complement rather than replace antiseizure medications.
The 500-participant study will assess whether pridopidine, an investigational sigma-1 receptor agonist, can slow functional decline and improve survival in patients with early, rapidly progressing amyotrophic lateral sclerosis.
Kiril Kiprovski, MD, clinical professor of neurology and director of the Division of Neuromuscular Medicine at NYU Langone, reviews the clinical clues, bedside tests, and referral considerations that help eye care clinicians identify Lambert-Eaton myasthenic syndrome in patients with fluctuating ptosis or diplopia.
IJMSC editor-in-chief, François Bethoux, MD, and colleagues cover idea generation, poster conversion, literature reviews, and peer review in a 4-part webinar series for MS clinicians.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
QurAlis Reports ANQUR Interim Data for STATHMIN-2-Targeting Agent QRL-201 in ALS
2
PREVAiLS Phase 3 Trial Evaluates Pridopidine in Early, Rapidly Progressive ALS
3
Sevasemten Misses Primary Endpoint in Pivotal Trial for Becker Muscular Dystrophy
4
Gray Areas: Is Preventing Frailty in Multiple Sclerosis a Realistic Goal?
5